Sciformix Corporation
Trending Articles
Related Content
Regulatory
The future of pharmacovigilance and the impact of automation
Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent years. David J. Balderson, Vice President, Global Safety Operations, Sciformix, a Covance company, reports
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Media
Automated and integrated drug safety database solution
Through its collaboration with Oracle Health Sciences, Sciformix is able to offer its customers a fully automated and integrated safety database solution, allowing easy reporting and analytics for improving the quality and efficiency of drug safety operations
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Creating proactive productvigilance systems
In addition to proof of drug effectiveness, pharmacovigilance has become an important safety requirement laid down by the regulators. Dr Chitra Lele, CSO, Sciformix Corporation, discusses the importance of establishing an effective global safety framework to meet today’s needs